Appili Therapeutics Stock Performance

APLI Stock  CAD 0.02  0.01  20.00%   
On a scale of 0 to 100, Appili Therapeutics holds a performance score of 2. The firm shows a Beta (market volatility) of -0.0864, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Appili Therapeutics are expected to decrease at a much lower rate. During the bear market, Appili Therapeutics is likely to outperform the market. Please check Appili Therapeutics' standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Appili Therapeutics' price patterns will revert.

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Appili Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Appili Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Financial Trading Report - news.stocktradersdaily.com
11/28/2025
2
Trend Tracker for - Stock Traders Daily
12/30/2025
3
Strategic Equity Report - Stock Traders Daily
01/28/2026
4
Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances - TipRanks
02/12/2026
Begin Period Cash Flow94.5 K
Total Cashflows From Investing Activities-2360.00
  

Appili Therapeutics Relative Risk vs. Return Landscape

If you would invest  2.50  in Appili Therapeutics on November 20, 2025 and sell it today you would lose (0.50) from holding Appili Therapeutics or give up 20.0% of portfolio value over 90 days. Appili Therapeutics is generating 0.4722% of daily returns and assumes 13.2059% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Appili on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Appili Therapeutics is expected to generate 17.44 times more return on investment than the market. However, the company is 17.44 times more volatile than its market benchmark. It trades about 0.04 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.18 per unit of risk.

Appili Therapeutics Target Price Odds to finish over Current Price

The tendency of Appili Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.02 90 days 0.02 
about 88.37
Based on a normal probability distribution, the odds of Appili Therapeutics to move above the current price in 90 days from now is about 88.37 (This Appili Therapeutics probability density function shows the probability of Appili Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Appili Therapeutics has a beta of -0.0864. This suggests as returns on the benchmark increase, returns on holding Appili Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Appili Therapeutics is likely to outperform the market. Additionally Appili Therapeutics has an alpha of 0.9533, implying that it can generate a 0.95 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Appili Therapeutics Price Density   
       Price  

Predictive Modules for Appili Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Appili Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0213.49
Details
Intrinsic
Valuation
LowRealHigh
0.000.0213.49
Details

Appili Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Appili Therapeutics is not an exception. The market had few large corrections towards the Appili Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Appili Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Appili Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.95
β
Beta against Dow Jones-0.09
σ
Overall volatility
0
Ir
Information ratio 0.06

Appili Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Appili Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Appili Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Appili Therapeutics had very high historical volatility over the last 90 days
Appili Therapeutics has some characteristics of a very speculative penny stock
Appili Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 100.44 K. Net Loss for the year was (2.62 M) with profit before overhead, payroll, taxes, and interest of 100.44 K.
Latest headline from news.google.com: Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances - TipRanks

Appili Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Appili Stock often depends not only on the future outlook of the current and potential Appili Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Appili Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding121.3 M
Cash And Short Term Investments1.2 M

Appili Therapeutics Fundamentals Growth

Appili Stock prices reflect investors' perceptions of the future prospects and financial health of Appili Therapeutics, and Appili Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Appili Stock performance.

About Appili Therapeutics Performance

By examining Appili Therapeutics' fundamental ratios, stakeholders can obtain critical insights into Appili Therapeutics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Appili Therapeutics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand2.1 K2.2 K
Return On Tangible Assets(1.00)(1.05)
Return On Capital Employed 0.02  0.02 
Return On Assets(1.00)(1.05)
Return On Equity 0.18  0.17 

Things to note about Appili Therapeutics performance evaluation

Checking the ongoing alerts about Appili Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Appili Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Appili Therapeutics had very high historical volatility over the last 90 days
Appili Therapeutics has some characteristics of a very speculative penny stock
Appili Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 100.44 K. Net Loss for the year was (2.62 M) with profit before overhead, payroll, taxes, and interest of 100.44 K.
Latest headline from news.google.com: Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances - TipRanks
Evaluating Appili Therapeutics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Appili Therapeutics' stock performance include:
  • Analyzing Appili Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Appili Therapeutics' stock is overvalued or undervalued compared to its peers.
  • Examining Appili Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Appili Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Appili Therapeutics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Appili Therapeutics' stock. These opinions can provide insight into Appili Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Appili Therapeutics' stock performance is not an exact science, and many factors can impact Appili Therapeutics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in Appili Stock

Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.